Safety and immunogenicity of NDV-HXP-S, phase 1 trial
收藏官方服务:
资源简介:
This study reports encouraging results from the first use of the NDV-HXP-S COVID-19 vaccine candidate in human subjects.
提供机构:
ImmPort创建时间:
2024-07-22

This study reports encouraging results from the first use of the NDV-HXP-S COVID-19 vaccine candidate in human subjects.